Sub Banner Image

Novo Nordisk calls for US import ban on key ingredient for obesity drug copycats

Business & Finance

·

August 6, 2025

·

Financial Times

Danish group loses share in diabetes drugs to rivals, with first-half sales growth easing to 8%

More from

Financial Times

More

Business & Finance

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.